24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction).

      1 , 1 , 1 , 1 , 2 , 2 , 1 , 3 , 1 , 4 , 4 , 4 , 5 , 6
      Journal of the American College of Cardiology
      Elsevier BV
      CDC, CK-MB, CT, DSMB, Data and Safety Monitoring Board, EDV, EF, ESV, Ecc, FWHM, ICD, LV, LVEF, MI, MRI, NYHA, New York Heart Association, SAE, TnI, Vo(2), cardiosphere-derived cell, cardiosphere-derived cells, computed tomography, creatine kinase-myocardial band, ejection fraction, end-diastolic volume, end-systolic volume, full width at half maximum, implantable cardioverter-defibrillator, left ventricular, left ventricular ejection fraction, magnetic resonance imaging, myocardial infarction, myocardial regeneration, oxygen consumption, serious adverse event(s), systolic circumferential strain, troponin I

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This study sought to report full 1-year results, detailed magnetic resonance imaging analysis, and determinants of efficacy in the prospective, randomized, controlled CADUCEUS (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction) trial.

          Related collections

          Author and article information

          Journal
          J Am Coll Cardiol
          Journal of the American College of Cardiology
          Elsevier BV
          1558-3597
          0735-1097
          Jan 21 2014
          : 63
          : 2
          Affiliations
          [1 ] Cedars-Sinai Heart Institute, Los Angeles, California.
          [2 ] Division of Cardiology, Department of Medicine, Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Northwestern Memorial Hospital, Chicago, Illinois.
          [3 ] EMMES Corporation, Rockville, Maryland.
          [4 ] Division of Cardiology, Department of Medicine, The Johns Hopkins University, Baltimore, Maryland.
          [5 ] Division of Cardiology, Department of Medicine, The Johns Hopkins University, Baltimore, Maryland; Department of Biomedical Engineering, The Johns Hopkins University, Baltimore, Maryland.
          [6 ] Cedars-Sinai Heart Institute, Los Angeles, California. Electronic address: eduardo.marban@csmc.edu.
          Article
          S0735-1097(13)04122-3 NIHMS523217
          10.1016/j.jacc.2013.08.724
          3947063
          24036024
          06ad1d92-3322-49c1-b6a3-4a763b45b22c
          Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
          History

          CDC,CK-MB,CT,DSMB,Data and Safety Monitoring Board,EDV,EF,ESV,Ecc,FWHM,ICD,LV,LVEF,MI,MRI,NYHA,New York Heart Association,SAE,TnI,Vo(2),cardiosphere-derived cell,cardiosphere-derived cells,computed tomography,creatine kinase-myocardial band,ejection fraction,end-diastolic volume,end-systolic volume,full width at half maximum,implantable cardioverter-defibrillator,left ventricular,left ventricular ejection fraction,magnetic resonance imaging,myocardial infarction,myocardial regeneration,oxygen consumption,serious adverse event(s),systolic circumferential strain,troponin I

          Comments

          Comment on this article